18 results with keyword: 'management of parkinson s disease'
The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are
N/A
Knobloch SC Introduction, November 2015 13 DDT: Main Window Process controls Process groups Source code Variables Expression evaluator Stack trace... DDT:
N/A
More individual foods from the cereals and legumes food groups were included in menus from Northern Ghana, while more individual foods from the tubers, dark, leafy green vegetables
N/A
3 Mild to moderate bilateral disease: some postural instability: Mild to moderate bilateral disease: some postural instability:.
N/A
PD: Parkinson ’ s disease; MCI: Mild cognitive impairment; PDD: Parkinson ’ s disease with dementia; UPDRS: Unified parkinson ’ s disease rating scale; H & Y: Hoehn and yahr
N/A
With all participants agreeing (albeit grudgingly on the part of Patrick Barry 1 ) that the current short-term growth measure is acceptable for MLPs as well as corporations, the
N/A
Delegations of Authority are reviewed annually by the Board of Directors, the Citi CEO and the Citi CFO and may be adjusted as necessary to accommodate business needs, geographic
N/A
PD: Parkinson ’ s Disease; MAO: Monoaminooxidase; LD: Levodopa; DDI: Dopadecarboxylase inhibitor; TEMPO: a controlled trial of rasagiline in early Parkinson ’ s disease;
N/A
Efficacious for symptomatic monotherapy, symptomatic therapy adjunct to levodopa, the prevention/delay and the treatment of motor
N/A
The polymer concentration determines the spinnability of a solution, namely whether a fibre forms or not [7]. al, reported that a different specific range of viscosity was
N/A
If the patient needs treatment for motor symp- toms, efficacious agents for initial therapy include levodopa, dopamine agonists, anticholinergic agents, amantadine, and
N/A
Due to the long lag between introducing cabergoline and development of motor benefit, patients need to reduce levodopa by the minimum amount (25 mg/ dose), once they
N/A
Biphasic dyskinesia L-dopa/DDI s/c apomorphine or liquid L-dopa Motor response Motor response Sleep Time Sleep Time. L-dopa/DDI L-dopa/DDI
N/A
Data were collected from 379 youth from a public Malaysian university across six schools of studies in a Malaysian public research- based university: the Academy of Islamic
N/A
PDQL: Parkinson ’ s disease quality of life; ADL: Activities of daily living; HY: Hoehn and Yahr; K-MMSE: Korean version of mini-mental status examin- ation; PD: Parkinson ’ s
N/A
AIM: MIG / MAG - This course aims to provide basic working knowledge and practical experience of welding of ferrous metals. TARGET GROUP: This course is designed for delegates with
N/A
MEDICAL NEGLIGENCE COMPENSATION QUESTIONNAIRE If you would like Fearon & Co to act for you in obtaining compensation for an accident you have been involved with then would
N/A
Expressed as levodopa, initially 50-100mg 3–4 times daily, increased by 100 mg daily once or twice weekly according to response;.. ELDERLY initially 50 mg once or twice daily,
N/A